PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 87 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 87 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | -50.0% | 87 | -64.2% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 243 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 243 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 243 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -33.3% | 243 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 243 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | -66.7% | 243 | 0.0% | 0.00% | – |
Q1 2019 | $9,000 | +125.0% | 243 | +17.4% | 0.00% | – |
Q4 2018 | $4,000 | -55.6% | 207 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | -25.0% | 207 | 0.0% | 0.00% | – |
Q2 2018 | $12,000 | -99.2% | 207 | -99.0% | 0.00% | -100.0% |
Q1 2018 | $1,476,000 | -24.4% | 21,694 | +9.9% | 0.01% | -14.3% |
Q4 2017 | $1,952,000 | – | 19,744 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |